HPV vaccine plus screening "economically attractive" for cervical cancer prevention

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.426, 2003-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Using HPV vaccine for cervical cancer prevention: not an easy task

Inpharma, Vol. 1, Iss. 1524, 2006-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Quadrivalent HPV vaccine may prevent cervical cancer

Inpharma, Vol. 1, Iss. 1467, 2004-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

HPV vaccine protects against cervical cancer precursors

Inpharma, Vol. 1, Iss. 1516, 2005-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

AS04-Adjuvanted Human Papillomavirus (HPV) Types 16 and 18 Vaccine (Cervarix®): A Review of its Use in the Prevention of Premalignant Cervical Lesions and Cervical Cancer Causally Related to Certain Oncogenic HPV Types

By McKeage Kate

Drugs, Vol. 71, Iss. 4, 2011-03 ,pp. : 465-468

Adis International

Access to resources Recommend Favorite

Potential HCV vaccine "highly economically attractive" in Canada

Inpharma, Vol. 1, Iss. 1477, 2005-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite